Patents by Inventor Robin Lee Keich

Robin Lee Keich has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7056492
    Abstract: The present invention relates to methods for treating or preventing a disease or disorder in an animal caused by infection by Mycoplasma bovis (M. bovis) by administering to the animal an effective amount of a Mycoplasma hyopneumoniae (M. hyo) vaccine. The M. hyo vaccine can be a whole or partial cell inactivated or modified live preparation, a subunit vaccine, or a nucleic acid or DNA vaccine. The M. hyo vaccine administered in accordance with the present invention can be synthesized or recombinantly produced.
    Type: Grant
    Filed: June 20, 2002
    Date of Patent: June 6, 2006
    Assignee: Pfizer Inc.
    Inventors: Alexander C. Goudie, Andrew Raymond Peters, Robin Lee Keich
  • Patent number: 6846477
    Abstract: The present invention relates to methods for treating or preventing a disease or disorder in an animal caused by infection by Mycoplasma hyopneumoniae (M. hyo) by administering to the animal at approximately three (3) to ten (10) days of age, a single dose of an effective amount of a M. hyo vaccine. The M. hyo vaccine can be a whole or partial cell inactivated or modified live preparation, a subunit vaccine, or a nucleic acid or DNA vaccine. The M. hyo vaccine administered in accordance with the present invention can be synthesized or recombinantly produced.
    Type: Grant
    Filed: June 19, 2002
    Date of Patent: January 25, 2005
    Assignees: Pfizer Inc., Pfizer Products Inc.
    Inventors: Robin Lee Keich, Lisa Grace Sabbadini
  • Publication number: 20030180219
    Abstract: The present invention provides a reproducible M. bovis challenge model and methods for reliably inducing and establishing a disease or disorder caused by infection with M. bovis by administering to an animal an effective amount of a M. bovis culture. The challenge culture of the present invention is administered in an amount sufficient to elicit M. bovis specific cellular or humoral immune responses. The M. bovis challenge model in accordance with the present invention can be used to evaluate the efficacy of potential vaccines.
    Type: Application
    Filed: August 26, 2002
    Publication date: September 25, 2003
    Applicant: Pfizer Inc.
    Inventors: Robin Lee Keich, Laszlo Pal Stipkovits
  • Publication number: 20030147914
    Abstract: The present invention relates to Mycoplasma bovis vaccines and methods for treating or preventing a disease or disorder in an animal caused by infection by Mycoplasma bovis by administering to the animal an effective amount of a Mycoplasma bovis vaccine. The Mycoplasma bovis vaccine can be a whole or partial cell inactivated or modified live preparation, a subunit vaccine, or a nucleic acid or DNA vaccine. The Mycoplasma bovis vaccine administered in accordance with the present can be synthesized or recombinantly produced. The invention also relates to combination vaccines, methods of preparing Mycoplasma bovis vaccines and kits.
    Type: Application
    Filed: June 20, 2002
    Publication date: August 7, 2003
    Applicant: Pfizer Inc.
    Inventors: Robin Lee Keich, David Ross McGavin, Robert J. Yancey
  • Publication number: 20030109473
    Abstract: The present invention relates to methods for treating or preventing a disease or disorder in an animal caused by infection by Mycoplasma hyopneumoniae (M. hyo) by administering to the animal at approximately three (3) to ten (10) days of age, a single dose of an effective amount of a M. hyo vaccine. The M. hyo vaccine can be a whole or partial cell inactivated or modified live preparation, a subunit vaccine, or a nucleic acid or DNA vaccine. The M. hyo vaccine administered in accordance with the present invention can be synthesized or recombinantly produced.
    Type: Application
    Filed: June 19, 2002
    Publication date: June 12, 2003
    Applicant: Pfizer Inc.
    Inventors: Robin Lee Keich, Lisa Grace Sabbadini
  • Publication number: 20030064079
    Abstract: The present invention relates to methods for treating or preventing a disease or disorder in an animal caused by infection by Mycoplasma bovis (M. bovis) by administering to the animal an effective amount of a Mycoplasma hyopneumoniae (M. hyo) vaccine. The M. hyo vaccine can be a whole or partial cell inactivated or modified live preparation, a subunit vaccine, or a nucleic acid or DNA vaccine. The M. hyo vaccine administered in accordance with the present invention can be synthesized or recombinantly produced.
    Type: Application
    Filed: June 20, 2002
    Publication date: April 3, 2003
    Applicant: Pfizer Inc.
    Inventors: Alexander C. Goudie, Andrew Raymond Peters, Robin Lee Keich
  • Patent number: RE44399
    Abstract: The present invention relates to methods for treating or preventing a disease or disorder in an animal caused by infection by Mycoplasma hyopneumoniae (M. hyo) by administering to the animal at approximately three (3) to ten (10) days of age, a single dose of an effective amount of a M. hyo vaccine. The M. hyo vaccine can be a whole or partial cell inactivated or modified live preparation, a subunit vaccine, or a nucleic acid or DNA vaccine. The M. hyo vaccine administered in accordance with the present invention can be synthesized or recombinantly produced.
    Type: Grant
    Filed: March 2, 2012
    Date of Patent: July 30, 2013
    Assignee: Zoetis LLC
    Inventors: Robin Lee Keich, Lisa Grace Sabbadini